NCT02927964 2024-10-16TLR9 Agonist SD-101, Ibrutinib, and Radiation Therapy in Treating Patients With Relapsed or Refractory Grade 1-3A Follicular LymphomaStanford UniversityPhase 1/2 Completed21 enrolled 11 charts
NCT02254772 2019-11-27A Phase I/II Study of Intratumoral Injection of SD-101Stanford UniversityPhase 1/2 Completed9 enrolled 10 charts